Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04184869
Title Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acrotech Biopharma LLC
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Belinostat

Atazanavir + Belinostat

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.